Author:
Nemesure Matthew D.,Heinz Michael V.,Huang Raphael,Jacobson Nicholas C.
Abstract
AbstractGeneralized anxiety disorder (GAD) and major depressive disorder (MDD) are highly prevalent and impairing problems, but frequently go undetected, leading to substantial treatment delays. Electronic health records (EHRs) collect a great deal of biometric markers and patient characteristics that could foster the detection of GAD and MDD in primary care settings. We approached the problem of predicting MDD and GAD using a novel machine learning pipeline to re-analyze data from an observational study. The pipeline constitutes an ensemble of algorithmically distinct machine learning methods, including deep learning. A sample of 4,184 undergraduate students completed the study, undergoing a general health screening and completing a psychiatric assessment for MDD and GAD. After explicitly excluding all psychiatric information, 59 biomedical and demographic features from the general health survey in addition to a set of engineered features were used for model training. We assessed the model's performance on a held-out test set and found an AUC of 0.73 (sensitivity: 0.66, specificity: 0.7) and 0.67 (sensitivity: 0.55, specificity: 0.7) for GAD, and MDD, respectively. Additionally, we used advanced techniques (SHAP values) to illuminate which features had the greatest impact on prediction for each disease. The top predictive features for MDD were being satisfied with living conditions and having public health insurance. The top predictive features for GAD were vaccinations being up to date and marijuana use. Our results indicate moderate predictive performance for the application of machine learning methods in detection of GAD and MDD based on EHR data. By identifying important predictors of GAD and MDD, these results may be used in future research to aid in the early detection of MDD and GAD.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Bystritsky, A., Khalsa, S. S., Cameron, M. E. & Schiffman, J. Current diagnosis and treatment of anxiety disorders. Pharm Ther. 38(1), 30–57 (2013).
2. Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289(23), 3095–3105. https://doi.org/10.1001/jama.289.23.3095 (2003).
3. Mathers C, Fat DM, Boerma JT, World Health Organization, eds. The Global Burden of Disease: 2004 Update. World Health Organization; 2008.
4. Reddy, M. S. Depression: the disorder and the burden. Indian J Psychol Med. 32(1), 1–2. https://doi.org/10.4103/0253-7176.70510 (2010).
5. Friedrich, M. J. Depression is the leading cause of disability around the world. JAMA 317(15), 1517–1517. https://doi.org/10.1001/jama.2017.3826 (2017).
Cited by
108 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献